Turim 21 Investimentos’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-363
Closed -$38 136
2025
Q3
$38 Hold
363
﹤0.01% 115
2025
Q2
$38 Hold
363
﹤0.01% 82
2025
Q1
$38 Hold
363
﹤0.01% 80
2024
Q4
$38 Hold
363
﹤0.01% 83
2024
Q3
$38 Hold
363
﹤0.01% 78
2024
Q2
$38 Hold
363
﹤0.01% 73
2024
Q1
$255 Hold
363
﹤0.01% 73
2023
Q4
$635 Hold
363
﹤0.01% 78
2023
Q3
$523 Hold
363
﹤0.01% 74
2023
Q2
$944 Hold
363
﹤0.01% 74
2023
Q1
$1.34K Hold
363
﹤0.01% 63
2022
Q4
$643 Hold
363
﹤0.01% 71
2022
Q3
$1K Hold
363
﹤0.01% 87
2022
Q2
$2K Hold
363
﹤0.01% 98
2022
Q1
$5K Hold
363
﹤0.01% 112
2021
Q4
$6K Hold
363
﹤0.01% 90
2021
Q3
$12K Hold
363
0.01% 81
2021
Q2
$15K Sell
363
-363
-50% -$14.9K 0.01% 91
2021
Q1
$37K Buy
+726
New +$38K 0.02% 47

Turim 21 Investimentos's DMTK Position: Q4 2025 in Review

Turim 21 Investimentos sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2025, closing a stake of 363 shares — an estimated $38 sold.

Turim 21 Investimentos first reported a position in DMTK in Q1 2021 and held it in 19 quarters. The position peaked at $37K in Q1 2021. 0 funds tracked by Wall St. Rank hold DMTK as of Q4 2025.

  • Turim 21 Investimentos reported no remaining DermTech, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Turim 21 Investimentos sold 363 DermTech, Inc. Common Stock shares in Q4 2025, an estimated $38.
  • Turim 21 Investimentos first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 19 quarters.
  • Turim 21 Investimentos's DermTech, Inc. Common Stock position peaked at $37K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2025.

Based on Turim 21 Investimentos's 13F filing for Q4 2025, filed 17 Feb 2026.